Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
| Data | Nome del titolare | Azioni transazionate | Intervallo di valore ($) | Tipo di transazione | Intervallo di prezzo ($) | Azioni a fine dichiarazione | % di variazione |
|---|---|---|---|---|---|---|---|
| 2026-03-27 | Mr. William L. AshtonIndependent Director | 350,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 0,36 | 440,00k | 388,89% |
| 2025-12-16 | Mr. Patrick J. MahaffyIndependent Director | 25,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 1,31 | 50,00k | 100,00% |
| 2025-12-16 | Dr. Raza BokhariCEO & Executive Chairman | 125,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 1,31 | 675,00k | 22,73% |
| 2025-12-16 | Mr. Ajay RajuDirector | 25,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 1,31 | 50,00k | 100,00% |
| 2025-12-16 | Mr. Robert Joseph CiaruffoliIndependent Lead Director | 25,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 1,31 | 90,00k | 38,46% |
| 2025-12-16 | Mr. Andrew Alasdair SmithCOO | 50,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 1,31 | 150,00k | 50,00% |
| 2025-12-16 | Mr. William L. AshtonIndependent Director | 25,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 1,31 | 90,00k | 38,46% |
| 2025-12-16 | Dr. Larry R. KaiserIndependent Director | 25,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 1,31 | 90,00k | 38,46% |
| 2025-12-16 | Dr. Edward J. BrennanChief Scientific Officer and Head of R&D Program | 50,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 1,31 | 195,00k | 34,48% |
| 2025-12-16 | Dr. Sara R. MayIndependent Director | 25,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 1,31 | 90,00k | 38,46% |
| 2025-12-16 | Ms. Carolyn BonnerInsider | 75,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 1,31 | 197,50k | 61,22% |
| 2025-12-16 | Dr. Faisal MehmudChief Medical Officer | 75,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 1,31 | 225,00k | 50,00% |
| 2025-12-16 | Hon. Cathy McMorris RodgersIndependent Director | 25,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 1,31 | 50,00k | 100,00% |
| 2025-08-13 | Mr. James P. QuinlanInsider | 145,00k | 162,70k | Derivative Exercise and Retained Stock | 0,84 - 2,87 | 274,15k | 112,27% |
Le azioni che visualizzerai appariranno in questo riquadro, così potrai facilmente tornare alle quotazioni di tuo interesse.
Assistenza: support@advfn.it
Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni
Registrati con e-mail
Hai già un account? Accedi
Non hai un account? Registrati
Registrandomi, confermo di aver letto, capito, e accetto i termini e condizioni ADVFN e che sono un investitore privato.
Caratteristiche principali
Premium
